MDT Stock Analysis: Buy, Sell, or Hold?
MDT - Medtronic plc
$87.16
1.24 (1.44%)
▲
5d:
+2.07%
30d:
+5.79%
90d:
+11.8%
BUY
HIGH Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Sep 01, 2026
23d
Smart Money Accumulation
None View Scanner →
Strength: 5.0/10
Get Alerted When MDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MDT shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
✅ BUY SIGNAL: MDT shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$123.64
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$76.77
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MDT is currently trading at $87.16, which is considered extended relative to its 30-day fair value range of $81.07 to $85.91. The stock's valuation (Forward PE: 14.4) is in line with its historical norms (14.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This pessimistic expectation contrasts with the company's recent 18.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, MDT is in a strong uptrend. The price is approaching resistance at $88.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $98.44 (+12.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDT is in a strong uptrend. The price is approaching resistance at $88.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $98.44 (+12.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$81.07 -
$85.91
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
59.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($98.44)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$81.07 -
$85.91
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$83.21
Resistance Level
$88.98
Current Trend
Strong Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.39
Wall Street Target
$98.44
(+12.9%)
Revenue Growth (YoY)
9.9%
Earnings Growth (YoY)
18.3%
Profit Margin
13.2%
Valuation Discount vs History
-0.7% cheaper
PE vs Historical
14.4 vs 14.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.7%
(market-implied from PE analysis)
1-Year Target
$86.55
(-1%)
2-Year Target
$85.94
(-1%)
3-Year Target
$85.34
(-2%)
3-Yr Target (if PE normalizes)
(PE: 14→15)
$87.20
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 9.6%)
$161.23
(+85%)
Base:
(SPY PE: 14.4, Growth: 9.6%)
$114.66
(+32%)
Bear:
(PE: 12.2, Growth: 9.6%)
$97.47
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 23.03 | Current EPS (TTM): $3.73
Bull Case
$153.51
(+76%)
Analyst growth 62.4%, PE expands to 25.3
Base Case
$139.55
(+60%)
Market implied 62.4%, PE stable at 23.0
Bear Case
$58.43
(-33%)
Severe decline -20.0%, PE contracts to 19.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.4 to 14.7
Stabilization Target:
$89.06
(+2.2%)
PE Expansion Potential:
+2.2%
Share & Embed Analysis
Last updated: August 08, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
Data refreshes hourly during market hours. Next update: 6:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Kevin Hern
SELL
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 43 HOLD |
Advanced MDT Option Strategies
Professional options setups generated by AI based on today's MDT price and gamma walls.
